Is CSPC Pharmaceutical Group Limited (CSPCY) a Buy, Sell, or Hold?
OTC : CSPCY
CSPC Pharmaceutical Group Limited — News
$4.25 USD
-$0.08 (-1.85%)
- Volume
- 5K
- Average Volume
- 1.6K
- Market Capitalization
- $12.24B
- P/E Ratio
- 21.19
- Dividend Yield
- 3.46%
- Price Target
- Year High
- $5.83
- Year Low
- $3.26
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.64
- Current Ratio
- $2.19
| Source | Headline |
|---|---|
|
AstraZeneca signs CSPC China deal for experimental kidney disease drugs
AstraZeneca has entered into a deal worth up to $1.77 billion with CSPC Pharmaceutical Group to discover and develop experimental medicines with the potential to treat kidney diseases, the Chinese drugmaker said on Thursday. reuters.com - 2026-07-02 06:16:16 |
